BURLINGTON, Mass., July 23 /PRNewswire-FirstCall/ -- Palomar Medical Technologies, Inc. (Nasdaq: PMTI), a leading researcher and developer of light-based systems for cosmetic treatments, will hold its quarterly conference call of its 2009 second quarter financial results on Thursday, July 30, 2009 at 11:30 AM Eastern Time. If you would like to participate, please call (866) 783-2146 at 11:20 AM Eastern Time on that day. The telephone replay will be available one hour after the call at (888) 286-8010 passcode 72567268 and continue through Thursday, August 13, 2009.
A live webcast of Palomar's conference call will be available in the Investor Relations' section of the Company's web site www.palomarmedical.com. Institutional investors can access the call via Thomson Financial's password-protected event management site, StreetEvents (www.streetevents.com). The online archive will be available one hour after the call and continue through Thursday, August 13, 2009.
For more information on Palomar and its products, visit Palomar's website at www.palomarmedical.com. To continue receiving the most up-to-date information and latest news on Palomar as it happens, sign up to receive automatic e-mail alerts by going to the Investor Relations' section of the website.
About Palomar Medical Technologies Inc.: Palomar is a leading researcher and developer of light-based systems for cosmetic treatments. Palomar pioneered the optical hair removal field, when, in 1997, it introduced the first high-powered laser hair removal system. Since then, many of the major advances in light-based hair removal have been based on Palomar technology. In December 2006, Palomar became the first company to receive a 510(k) over-the-counter (OTC) clearance from the United States Food and Drug Administration (FDA) for a new, patented, home use, light-based hair removal device. In June 2009, Palomar became the first company to receive a 510(k) OTC clearance from the FDA for a new, patented home use, laser device for the treatment of periorbital wrinkles. OTC clearance allows products to be marketed and sold directly to consumers without a prescription. There are now millions of light-based cosmetic procedures performed around the world every year in physician offices, clinics, spas and salons. Palomar is testing many new and exciting applications to further advance hair removal, skin rejuvenation and other cosmetic applications. Palomar is focused on developing proprietary light-based technology for introduction to the mass markets. Palomar has granted The Procter & Gamble Company a non-exclusive license to certain patents, technology and FDA documents related to the home-use, light-based hair removal field for women. In addition, Palomar has an exclusive development and license agreement with Johnson & Johnson Consumer Companies to develop and potentially commercialize home-use, light-based devices for reducing or reshaping body fat including cellulite, reducing the appearance of skin aging, and reducing or preventing acne.
Contacts: Kayla Castle Investor Relations Manager Palomar Medical Technologies, Inc. 781-993-2411 email@example.com
|SOURCE Palomar Medical Technologies, Inc.|
Copyright©2009 PR Newswire.
All rights reserved